Pratz KW, Jonas BA, Pullarkat V, Recher C, et al. Measurable Residual Disease Response and Prognosis in Treatment-Naive Acute Myeloid Leukemia With Venetoclax and Azacitidine. J Clin Oncol 2021 Dec 15:JCO2101546. doi: 10.1200/JCO.21.01546.
PMID: 34910556